NCT01935089View on ClinicalTrials.gov

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 7, 2013

Primary Completion Date

March 25, 2015

Study Completion Date

May 2, 2016

Conditions
HIV-1 Infection
Interventions
DRUG

Pegylated Interferon alpha 2b

1µg/kg/week

Trial Locations (3)

19104

AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia

Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia

19107

Jonathan Lax Clinic, Philadelphia FIGHT, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

The Wistar Institute

OTHER

NCT01935089 - Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV | Biotech Hunter | Biotech Hunter